Nadda: India's HPV Drive Crosses 1 Crore Doses, Hits 87% Coverage
Synopsis
Key Takeaways
Less than nine months after Prime Minister Narendra Modi launched it, India's National HPV Vaccination Campaign has crossed 1 crore doses — shielding nearly 87 percent of the annual cohort of eligible girls from cervical cancer, one of the most preventable yet persistently deadly cancers among Indian women. Union Health Minister J. P. Nadda announced the milestone on Saturday, 21 November 2026, calling it a historic step in protecting India's daughters.
Six States Hit 100% — and a Dozen More Cross 80%
The numbers behind the headline are striking. Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar have each achieved 100% coverage of their eligible cohorts — a list that spans geography, population size, and administrative complexity, from the tribal northeast to the Hindi heartland. A further 12 states have surpassed the 80% mark, signalling that this is not a metro-centric success story but a nationwide push that has reached district hospitals, primary health centres, and the last-mile frontline worker.
The campaign targets 14-year-old girls and delivers a single-dose HPV vaccine free of cost through government health facilities and the U-WIN digital platform, which tracks routine vaccination records. The single-dose protocol — aligned with updated WHO guidance — dramatically simplifies logistics compared with earlier multi-dose schedules, a design choice that appears to have paid off in coverage velocity.
Why Cervical Cancer Made This Urgent
Cervical cancer remains one of the leading causes of cancer-related mortality among Indian women. The disease is caused in the overwhelming majority of cases by persistent infection with the Human Papillomavirus (HPV), making vaccination at pre-exposure age the single most effective preventive tool available. India's Universal Immunisation Programme has historically focused on early-childhood diseases; the HPV campaign marks a deliberate expansion into adolescent preventive health — a structural shift in how the government frames the programme's ambition.
Nadda credited the result to 'the collective commitment of States/UTs, healthcare professionals, frontline health workers and parents across the country' — a coalition that, in practice, means ASHA workers, school-level outreach, and state health secretaries all pulling in the same direction simultaneously.
What 87% in Nine Months Actually Means
Reaching 87% of an annual birth cohort in under nine months for a brand-new adolescent vaccine — not a childhood jab with decades of infrastructure behind it — is a logistical achievement worth contextualising. Adolescent vaccination programmes globally have historically struggled with school-based access gaps, parental hesitancy, and cold-chain constraints. India's result, if sustained, would place the country on a trajectory toward the WHO's 90% coverage target for cervical cancer elimination — a goal that requires sustained high coverage over multiple years, not a single sprint.
The U-WIN platform's role in tracking coverage in real time gave administrators a live dashboard to identify lagging districts and redirect outreach — a data-driven accountability layer that older immunisation drives lacked.
One crore doses in nine months is a number. Preventing a generation of Indian women from ever facing a cervical cancer diagnosis is the point — and the campaign is now close enough to make that future feel real.